• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素激动剂敏感型和耐药型子宫肌瘤中雌激素受体-α、孕激素受体和钙调蛋白表达的比较

Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.

作者信息

Kim Eun Hee, Kim Joo Young, Lee Yoon Hee, Chong Gun Oh, Park Ji Young, Hong Dae Gy

机构信息

Gynecologic Cancer Center, Kyungpook National University Medical Center, Daegu, Korea.

Department of Pathology, Kyungpook National University Medical Center, Daegu, Korea.

出版信息

Obstet Gynecol Sci. 2014 Mar;57(2):144-50. doi: 10.5468/ogs.2014.57.2.144. Epub 2014 Mar 15.

DOI:10.5468/ogs.2014.57.2.144
PMID:24678488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3965698/
Abstract

OBJECTIVE

This study was aimed to compare immunohistochemical expression of estrogen receptor (ER)-α, progesterone receptor (PR), and calponin in gonadotrophin-releasing hormone agonist (GnRH-a)-sensitive and -resistant uterine fibroids.

METHODS

We collected data retrospectively. The sensitive group consisted of women who had reduction in uterine volume greater than 40% following GnRH-a treatment. Uterine volume was either reduced by less than 10%, or was increased in the resistant group. A tissue microarray was constructed using formalin-fixed, paraffin-embedded tissues, 31 and 26 patients for the sensitive and resistant groups, respectively. Tissue sections were immunostained with antibodies against ER-α, PR, and calponin. The intensity and area of the immunohistochemical reactions were evaluated using a semi-quantitative scoring system. The Mann-Whitney U-test, Fisher's exact test, and Spearman's rank correlation test were used for analysis of data.

RESULTS

PR (P = 0.04) and calponin (P = 0.03) showed a significantly higher staining intensity in the resistant group than in the sensitive group. Both groups showed comparable expression of ER-α (P = 0.23). In correlation analysis between changes in uterine volume after GnRH-a therapy and clinicopathological factors, the immunohistochemical intensity of PR (P = 0.04) and calponin (P = 0.03) was significantly correlated with changes in uterine volume.

CONCLUSION

This study shows that GnRH-a resistance of uterine fibroids is not related to ER-α content, but the expression of PR and calponin is related with GnRH-a resistance.

摘要

目的

本研究旨在比较促性腺激素释放激素激动剂(GnRH-a)敏感型和抵抗型子宫肌瘤中雌激素受体(ER)-α、孕激素受体(PR)和钙调蛋白的免疫组化表达。

方法

我们进行回顾性数据收集。敏感组由接受GnRH-a治疗后子宫体积缩小超过40%的女性组成。抵抗组子宫体积缩小小于10%或增大。使用福尔马林固定、石蜡包埋的组织构建组织芯片,敏感组和抵抗组分别有31例和26例患者。组织切片用抗ER-α、PR和钙调蛋白的抗体进行免疫染色。使用半定量评分系统评估免疫组化反应的强度和面积。采用曼-惠特尼U检验、费舍尔精确检验和斯皮尔曼等级相关检验进行数据分析。

结果

PR(P = 0.04)和钙调蛋白(P = 0.03)在抵抗组中的染色强度显著高于敏感组。两组ER-α的表达相当(P = 0.23)。在GnRH-a治疗后子宫体积变化与临床病理因素的相关性分析中,PR(P = 0.04)和钙调蛋白(P = 0.03)的免疫组化强度与子宫体积变化显著相关。

结论

本研究表明,子宫肌瘤的GnRH-a抵抗与ER-α含量无关,但PR和钙调蛋白的表达与GnRH-a抵抗有关。

相似文献

1
Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.促性腺激素释放激素激动剂敏感型和耐药型子宫肌瘤中雌激素受体-α、孕激素受体和钙调蛋白表达的比较
Obstet Gynecol Sci. 2014 Mar;57(2):144-50. doi: 10.5468/ogs.2014.57.2.144. Epub 2014 Mar 15.
2
Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.未治疗及促性腺激素释放激素激动剂预处理女性子宫肌瘤中类固醇受体结合及信使核糖核酸表达
Clin Endocrinol (Oxf). 1994 Apr;40(4):537-44. doi: 10.1111/j.1365-2265.1994.tb02495.x.
3
Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.接受促性腺激素释放激素激动剂醋酸亮丙瑞林治疗的女性的子宫肌瘤和子宫肌层类固醇受体。
Fertil Steril. 1990 Jun;53(6):1018-23.
4
Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.雌激素缺乏导致子宫平滑肌瘤细胞中的DNA损伤:GnRH激动剂使肌瘤缩小的一种可能机制。
BJOG. 2001 Jan;108(1):95-102. doi: 10.1111/j.1471-0528.2001.00013.x.
5
Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.短期使用选择性孕激素受体调节剂或促性腺激素释放激素激动剂后子宫肌瘤的缩小
Obstet Gynecol Sci. 2017 Jan;60(1):69-73. doi: 10.5468/ogs.2017.60.1.69. Epub 2017 Jan 19.
6
Estrogen and progesterone receptor content in the pituitary gland and uterus of progesterone-primed and gonadotropin releasing hormone-treated anestrous ewes.
Theriogenology. 2002 Apr 1;57(6):1719-31. doi: 10.1016/s0093-691x(02)00665-9.
7
Tamoxifen induces gonadotropin-releasing hormone self-priming through an estrogen-dependent progesterone receptor expression in the gonadotrope of the rat.他莫昔芬通过大鼠促性腺激素细胞中雌激素依赖性孕酮受体表达诱导促性腺激素释放激素自我启动。
Neuroendocrinology. 2003 Jun;77(6):425-35. doi: 10.1159/000071314.
8
Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.用促性腺激素释放激素类似物抑制雌激素后子宫肌层和平滑肌瘤组织中雌激素和孕激素受体的水平
Gynecol Endocrinol. 2001 Dec;15 Suppl 6:61-8.
9
Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.人子宫肌层和子宫肌瘤中的性类固醇受体:月经周期及促性腺激素释放激素治疗期间的变化
J Clin Endocrinol Metab. 1998 Nov;83(11):4092-6. doi: 10.1210/jcem.83.11.5287.
10
Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.GnRH 激动剂治疗的子宫平滑肌瘤中的细胞增殖、雌激素受体、孕激素受体及 bcl-2 表达
Hum Pathol. 1998 Apr;29(4):359-63. doi: 10.1016/s0046-8177(98)90116-2.

引用本文的文献

1
Short-term relugolix use for rapidly growing uterine fibroids before uterus-preserving surgery in women seeking to conceive: Two case reports.在寻求受孕的女性中,于保留子宫手术前短期使用relugolix治疗快速生长的子宫肌瘤:两例病例报告。
J Obstet Gynaecol Res. 2025 May;51(5):e16312. doi: 10.1111/jog.16312.
2
Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.子宫平滑肌瘤发生和生长所涉及分子机制的流行病学及遗传学线索
Hum Reprod Update. 2015 Sep-Oct;21(5):593-615. doi: 10.1093/humupd/dmv030. Epub 2015 Jul 3.

本文引用的文献

1
Analysis of factors affecting vaginal hysterectomy.影响阴道子宫切除术的因素分析。
Minim Invasive Ther Allied Technol. 2009;18(6):317-21. doi: 10.3109/13645700903201340.
2
Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.促性腺激素释放激素激动剂(GnRH-a)治疗子宫平滑肌瘤的病理评估:肥大细胞的作用及平滑肌瘤中GnRH-a抵抗的可能机制
Pathol Int. 2008 May;58(5):268-74. doi: 10.1111/j.1440-1827.2008.02222.x.
3
Steroid receptors in canine and human female genital tract tumours with smooth muscle differentiation.
J Comp Pathol. 2007 Feb-Apr;136(2-3):197-201. doi: 10.1016/j.jcpa.2007.01.004. Epub 2007 Mar 23.
4
Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.免疫组化标志物在子宫内膜间质肉瘤与细胞性平滑肌瘤鉴别诊断中的应用
Gynecol Oncol. 2004 Jan;92(1):71-9. doi: 10.1016/j.ygyno.2003.08.038.
5
Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.术前促性腺激素释放类似物对接受子宫切除术或肌瘤切除术的子宫肌瘤女性的疗效:一项系统评价。
BJOG. 2002 Oct;109(10):1097-108. doi: 10.1111/j.1471-0528.2002.01225.x.
6
Heparin inhibits proliferation of myometrial and leiomyomal smooth muscle cells through the induction of alpha-smooth muscle actin, calponin h1 and p27.肝素通过诱导α-平滑肌肌动蛋白、钙调蛋白h1和p27来抑制子宫肌层和平滑肌瘤平滑肌细胞的增殖。
Mol Hum Reprod. 1999 Feb;5(2):139-45. doi: 10.1093/molehr/5.2.139.
7
Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism.p53过表达在淋巴结阴性乳腺癌中的预后意义:初步研究支持谨慎乐观的态度。
J Natl Cancer Inst. 1993 Feb 3;85(3):176-7. doi: 10.1093/jnci/85.3.176.
8
The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study.米非司酮和醋酸亮丙瑞林对子宫肌瘤子宫动脉血流的影响:一项前瞻性随机研究。
Am J Obstet Gynecol. 1994 Jun;170(6):1623-7; discussion 1627-8.
9
Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.未治疗及促性腺激素释放激素激动剂预处理女性子宫肌瘤中类固醇受体结合及信使核糖核酸表达
Clin Endocrinol (Oxf). 1994 Apr;40(4):537-44. doi: 10.1111/j.1365-2265.1994.tb02495.x.
10
Estrogen and progesterone receptor content of enucleated uterine myomata after luteinizing hormone-releasing hormone. Analogue depot therapy.
Acta Obstet Gynecol Scand. 1994 Apr;73(4):328-32. doi: 10.3109/00016349409015773.